Susquehanna International Group’s Biofrontera BFRIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83K Sell
45,804
-2,694
-6% -$144 ﹤0.01% 13021
2025
Q4
$4.36K Buy
48,498
+2,611
+6% +$242 ﹤0.01% 12099
2025
Q3
$4.78K Buy
45,887
+34,088
+289% +$4.28K ﹤0.01% 12134
2025
Q2
$1.24K Buy
+11,799
New +$996 ﹤0.01% 12507
2024
Q2
Sell
-16,962
Closed -$1.15K 12049
2024
Q1
$1.15K Sell
16,962
-419
-2% -$12 ﹤0.01% 12009
2023
Q4
$90 Buy
17,381
+5,526
+47% +$138 ﹤0.01% 12240
2023
Q3
$462 Buy
+11,855
New +$1.07K ﹤0.01% 11901
2023
Q2
Sell
-13,485
Closed -$3.3K 12067
2023
Q1
$3.3K Sell
13,485
-7,622
-36% -$1.91K ﹤0.01% 12337
2022
Q4
$4.24K Sell
21,107
-1,742
-8% -$704 ﹤0.01% 12066
2022
Q3
$14K Sell
22,849
-3,303
-13% -$2.06K ﹤0.01% 12713
2022
Q2
$18K Buy
+26,152
New +$28.8K ﹤0.01% 12387

Other funds holding BFRIW

Susquehanna International Group's BFRIW Position: Q1 2026 in Review

Susquehanna International Group reduced its Biofrontera (BFRIW) stake by 5.6% in Q1 2026, selling an estimated $144 and leaving 45,804 shares worth $1.83K. The position accounts for ﹤0.01% of the portfolio, ranked #13021.

Susquehanna International Group first reported a position in BFRIW in Q2 2022 and has held it in 11 quarters since. The position peaked at $18K in Q2 2022. 6 funds tracked by Wall St. Rank hold BFRIW as of Q1 2026.

  • Susquehanna International Group held 45,804 shares of Biofrontera worth $1.83K as of Q1 2026.
  • Susquehanna International Group sold 2,694 Biofrontera shares in Q1 2026, an estimated $144.
  • Biofrontera made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #13021 holding.
  • Susquehanna International Group first reported a position in Biofrontera in Q2 2022 and has held it in 11 quarters since.
  • Susquehanna International Group's Biofrontera position peaked at $18K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.